Ticker brief

MODD MODULAR MEDICAL INC

Consumer, Non-cyclical · Pharmaceuticals

last close
$4.60
1 day
-1.7%
14 days
-10.7%
mkt cap
·
signals 14d
29
authors 14d
10
Sentiment — last 14 days
daily mean sentiment, 2026-06-24 → 2026-07-02 · now +0.23 (−1 bearish … +1 bullish)
Who spoke10
authorgradetrader scoresignalsmean sent
@VistaPResearchC·17+0.26
@BenzingaC-2.473+0.45
@AccesswireNewsC·2+0.28
@abc51648039C+1.801+0.45
@TT_stocks_C+2.391+0.60
@MrMTradesC-3.021+0.55
@JTE_ThetaCoC+0.571+0.55
@PennyboisTradesC+1.661+0.55
@MacroGekkoC-1.031+0.55
@d__riskB·1-0.15
Recent signals29of 29 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-07-02@VistaPResearch+0.15Promotional thematic article title frames listed tickers as a smart side hustle.—
2026-07-02@VistaPResearch+0.30Article title pitches Modular Medical's pivot and easier diabetes care.—
2026-07-01@VistaPResearch+0.20Daily market headline says listed tickers rise.-1.7%
2026-07-01@VistaPResearch+0.25MODD reported up 4.91% to 4.72.-1.7%
2026-07-01@VistaPResearch+0.00Article headline frames sub-100K payroll print implications for risk book.-1.7%
2026-07-01@VistaPResearch+0.20RGC surged 35.31% and MODD up 3.17%.-1.7%
2026-07-01@VistaPResearch+0.35Article title says Modular Medical's Pivot Pump could reprice diabetes convenience.-1.7%
2026-07-01@VistaPResearch+0.20MODD reported up 1.78% to 4.58.-1.7%
2026-07-01@VistaPResearch+0.25Article title on Modular Medical pivot and easier diabetes care.-1.7%
2026-06-30@VistaPResearch+0.25Article title about Modular's Pivot and Insulet's Omnipod rewriting diabetes playbook.+2.2%
2026-06-30@Benzinga+0.45Modular Medical advances commercial rollout with first active users of Pivot insulin pump.+2.2%
2026-06-30@d__risk-0.15MODD 10-K shifts to first Pivot pump launch while flagging commercialization and dilution risks.+2.2%
2026-06-30@MacroGekko+0.55Reports MODD entered patient adoption phase and is shipping Pivot insulin pumps to doctors.+2.2%
2026-06-30@PennyboisTrades+0.55MODD Pivot commercial launch with first trained patients using pump in real world.+2.2%
2026-06-30@JTE_ThetaCo+0.55Reports first patients using Pivot insulin patch pump and commercial-stage milestone.+2.2%
2026-06-30@MrMTrades+0.55MODD commercial insulin pump rollout with first patients using FDA-cleared Pivot pump.+2.2%
2026-06-30@Benzinga+0.45Modular Medical says first patients began using its Pivot tubeless insulin patch pump.+2.2%
2026-06-29@VistaPResearch+0.25Article title about Modular's Pivot and Insulet's Omnipod rewriting diabetes playbook.-5.7%
2026-06-29@VistaPResearch+0.35MODD reported surged 12.96% to 5.58.-5.7%
2026-06-26@VistaPResearch+0.40MODD reported surged 19.90% to 4.94.-6.9%
2026-06-26@TT_stocks_+0.60Recaps alerting MODD before a 30% halt up.-6.9%
2026-06-26@VistaPResearch+0.30Article title speculates Pivot could put Modular Medical on takeover radar.-6.9%
2026-06-26@VistaPResearch+0.30Article title speculates Pivot could put Modular Medical on takeover radar.-6.9%
2026-06-26@VistaPResearch+0.45Modular Medical announces shipment of Pivot tubeless patch pumps.-6.9%
2026-06-26@AccesswireNews+0.25Company announces shipment of Pivot tubeless patch pumps.-6.9%
2026-06-25@VistaPResearch+0.20Article frames diabetes and GLP-1 drugs as reshaping diabetes care.+11.7%
2026-06-24@AccesswireNews+0.30Modular Medical announces commercial availability of Pivot tubeless insulin patch pump.+9.7%
2026-06-24@Benzinga+0.45Modular Medical announces U.S. commercial availability of Pivot insulin patch pump.+9.7%
2026-06-24@abc51648039+0.45Arabic watchlist gives MODD target 4.97 and support break at 4.22.+9.7%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.